Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam Nanocrystal Injection for Postoperative Abdominal Pain
CTR20230228Phase 3Completed
- Sponsor
- CSPC Pharmaceutical Group
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Meloxicam nanocrystal injection with Placebo (normal saline) (2 arms). Primary endpoint: SPID24. Started Jan 2023; status: completed.
02
Drugs
meloxicam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20230228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230228.